Frontlight ResearchEarly access
TerminatedNo phase
A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain Tumors
Key facts
- Who runs it
- M.D. Anderson Cancer Center
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 10 people enrolled
- Started
- 5 Jun 2023
- Ended
- 28 Jul 2025
- Type of study
- Interventional
- Treatments tested
- Standard Fitbit Program
- Virtual Exercise Program
- Record updated
- 1 August 2025
- Why it stopped
- \<75% participation
Who can take part
- Age
- 15 years to 39 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age 15-39 years old
- Self-reported diagnosis of a primary benign or malignant brain tumor or confirmed diagnosis of primary benign or malignant brain tumor radiographically or pathologically when available (relapse or newly diagnosed)
- Plans to receive CRT at MDACC or, if the participant has already started CRT, the participant is eligible if they are within 3 weeks of the start of CRT
- Received appropriate physician clearance
- Able to move arms and legs, and ambulate safely
- Participant is insufficiently active (reports less than 150 minutes of planned moderate-vigorous intensity activity per week in the prior week)
- Participants and/or guardians are willing and able to provide informed consent
- Has a smartphone with available space to download additional apps
- Does not have sensorimotor strip impairment as indicated by the clinical team
- Has internet access
- Can receive physical therapy because this is part of the standard of care
- Participants and/or guardians are willing and able to provide informed consent for protocol PA18-0130 (Pediatric Energy Balance Data Repository Study), companion protocol for the Fitbit application/assessment
Who cannot take part
- Screen failure for exercise safety based on Physical Activity Readiness Questionnaire (PAR-Q).12
- Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
- Non-English speaking
- Recent fracture or acute musculoskeletal injury that precludes ability to participate in supervised exercise training sessions
- Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team
- Self-reported diagnosis of a metastatic brain tumor or confirmed diagnosis of a metastatic brain tumor radiographically or pathologically when available
- Self-report of pregnancy
- Currently enrolled in another physical activity or exercise intervention
- Prisoners
- Self-reported pregnancy status
Where in United States
- M D Anderson Cancer CenterHouston, United States
About the trial
What the trial wants to find out
To test a new investigational virtual exercise program for adolescents and young adults (AYAs) with brain tumors who plan to receive cranial radiotherapy
The group in the trial
- ActigraphTreatment being tested
A device worn on the waist that measures physical activity (such as the number of steps participants walk each day, how long participants spend standing, and how long partticipants spend laying down). Participants should wear the ActiGraph at least 10 hours a day for 7 days.
Treatment: Standard Fitbit Program and Virtual Exercise Program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 1 August 2025